If you've spent any time around clinical research, you've probably encountered the term CTIMP — a Clinical Trial of an Investigational Medicinal Product. What's less often explained is everything that sits outside that definition: the enormous range of research known, somewhat unhelpfully, as "non-CTIMP."
CTIMP vs non-CTIMP: the core distinction
| CTIMP | Non-CTIMP | |
|---|---|---|
| Definition | Tests an investigational medicinal product | Does not involve an investigational medicine |
| Regulatory framework | UK Clinical Trials Regulations; MHRA oversight | No single regulatory framework; varies by study type |
| Ethics review required? | Yes — mandatory | Yes — still required for most research involving people |
| Risk profile | Can be high; medicinal risk to participants | Varies widely; not automatically lower-stakes |
| Sponsor obligations | Extensive; defined in legislation | Less prescriptive, but responsibilities remain |
What actually counts as non-CTIMP research
Non-CTIMP research covers any study that doesn't involve testing an investigational medicine — which, in practice, means a great deal of research. Common examples include:
- Observational studies and prospective cohort studies
- Surveys, interviews, and focus groups
- Research using CE-marked medical devices
- Nutritional, dietary, and lifestyle intervention studies
- Real-world evidence studies and registry-based research
- Secondary analysis of existing data or biological samples
The common thread is simply that the study isn't investigating a new medicinal product — not that it's automatically simpler or lower-stakes.
Why ethical review still matters here
It's a common misconception that because non-CTIMP research sits outside the most heavily regulated category of clinical trials, it needs less ethical thought. In reality, many non-CTIMP studies involve exactly the things that ethical review exists to consider carefully: personal and sometimes sensitive data, vulnerable groups, questions of consent and withdrawal, and conclusions that may shape practice or policy. The regulatory label changes; the underlying responsibility to participants does not.
Where the questions tend to show up
An observational study following people with a long-term condition raises questions about burden and confidentiality over time. A dietary intervention study raises questions about safety, suitability, and clear communication of what participants are committing to. A piece of secondary research using existing health records raises questions about consent, anonymisation, and the boundaries of what that data was originally collected for. Each looks straightforward on the surface; each rewards careful thought underneath.
Getting started on the right foot
If you're new to this kind of research, the most useful early step is simply to ask: who is affected by this study, what are we asking of them, and what could reasonably go wrong? Bringing those questions to an independent ethics review early — rather than treating it as a final formality — tends to produce better-designed studies, smoother approvals, and far fewer surprises once recruitment is under way.
